The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this ...

Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.

Compounding pharmacies are illegally selling GLP-1 drugs, and the FDA is determined to shut that pathway down.

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

What do you associate with the word "generic?" Do the words "inferior" or "tastes like cardboard" come to mind? Or do you, like many people, associate name brands with people who are well-to-do, while ...

The U.S. health-care system is at a crossroads. Generic drugs and biosimilars have the potential to reduce costs and improve access to life-saving treatments, but outdated policies and entrenched ...

A new analysis from GoodRx explores how 2025 is shaping up for Food and Drug Administration drug approvals, and the early data tells a mixed story. Importantly, a growing disconnect remains between ...

“Million Bazillion” listener Kade wants to know why brand-name products cost more than store-brand and generic products. Bridget and Ryan head to a grocery store where they meet a talking can of soup ...